The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and efficacy of adoptive cell transfer using autologous tumor infiltrating lymphocytes (LN-145) for treatment of recurrent, metastatic, or persistent cervical carcinoma.
 
Amir A. Jazaeri
Honoraria - Gerson Lehrman Group
Consulting or Advisory Role - Almac Group; Aravive; Genentech/Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); immatics (Inst); Iovance Biotherapeutics (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Emese Zsiros
Consulting or Advisory Role - Iovance Biotherapeutics
Research Funding - Merck; X4 Pharma
Travel, Accommodations, Expenses - Apellis Pharmaceuticals
 
Rodabe Navroze Amaria
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); iovance Biotherapeutics (Inst); Merck (Inst); Novartis (Inst)
 
Andrew S. Artz
Research Funding - Miltenyi Biotec
 
Robert P. Edwards
No Relationships to Disclose
 
Robert Michael Wenham
Stock and Other Ownership Interests - Ovation Diagnostics
Honoraria - Tesaro
Consulting or Advisory Role - Clovis Oncology; Genentech; Merck; Mersana; Tesaro
Speakers' Bureau - Clovis Oncology; Genentech; Tesaro
Research Funding - Merck (Inst); Prescient Therapeutics (Inst)
Travel, Accommodations, Expenses - TapImmune Inc.
 
Brian M. Slomovitz
Consulting or Advisory Role - Agenus; AstraZeneca; Clovis Oncology; Genentech; Genentech; Incyte; Tesaro
 
Axel Walther
Consulting or Advisory Role - Tesaro
Speakers' Bureau - Tesaro
Travel, Accommodations, Expenses - Tesaro
 
Sajeve Samuel Thomas
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Ipsen; Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Merck
Speakers' Bureau - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Ipsen; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Genentech; Idera; Iovance Biotherapeutics; Merck; Pisces
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bristol-Myers Squibb; Genentech; Ipsen; Merck; Novartis
 
Jason Alan Chesney
Consulting or Advisory Role - Amgen; Replimune
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; MedImmune; MedImmune; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
Travel, Accommodations, Expenses - Amgen; Replimune
 
Robert Morris
Honoraria - AstraZeneca; Clovis Oncology; Janssen; Tesaro
Consulting or Advisory Role - Clovis Oncology
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Tesaro
 
KOJI MATSUO
No Relationships to Disclose
 
Stephanie Gaillard
Honoraria - Merck; Merck
Consulting or Advisory Role - Genentech/Roche; Merck; Pfizer; Tesaro
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Gradalis (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); PharmaMar (Inst); TetraLogic Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Sermonix Pharmaceuticals
 
Peter Graham Rose
No Relationships to Disclose
 
Jesus Garcia Donas
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; Pfizer; PharmaMar; Roche
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Pfizer; PharmaMar; Pierre Fabre; Roche
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Novartis; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD; Novartis; PharmaMar; Pierre Fabre
 
Jacqueline Maria Tromp
No Relationships to Disclose
 
Fatemeh Tavakkoli
Employment - Iovance Biotherapeutics
 
Huiling Li
Employment - Iovance Biotherapeutics
Stock and Other Ownership Interests - Iovance Biotherapeutics
 
Maria Fardis
Employment - Acerta Pharma; Iovance Biotherapeutics
Leadership - Acerta Pharma; Iovance Biotherapeutics
Stock and Other Ownership Interests - Abbvie; Acerta Pharma; Gilead Sciences; Iovance Biotherapeutics
Patents, Royalties, Other Intellectual Property - Acerta Pharma (Inst); Iovance Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Acerta Pharma; Iovance Biotherapeutics
 
Bradley J. Monk
Leadership - US Oncology
Honoraria - Abbvie; Advaxis; Amgen; Amgen; AstraZeneca; Bayer; Biodesix; Biodesix; Clovis Oncology; Genmab; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Janssen; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Samumed; Samumed; Takeda; Tesaro; VBL Therapeutics
Consulting or Advisory Role - Abbvie; Advaxis; Amgen; AstraZeneca; Bayer; Biodesix; Cerulean Pharma; Clovis Oncology; GlaxoSmithKline; Gradalis; Immunogen; Incyte; Insys Therapeutics; Mateon Therapeutics; Merck; Myriad Pharmaceuticals; Nucana; Oxigene; Perthera; Pfizer; Precision Oncology; Roche/Genentech; Tesaro; Verastem; Vermillion
Speakers' Bureau - AstraZeneca; Clovis Oncology; Janssen; Roche/Genentech; Tesaro
Research Funding - Advaxis (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Genentech (Inst); Immunogen (Inst); Janssen (Inst); Lilly (Inst); Morphotek (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Regeneron (Inst); Tesaro (Inst)